Target intelligence / Profile preview

RNA, U6 small nuclear 1017, pseudogene (RNU6-1017P)

Target
RNU6-1017P
Molecular classification
Other (pseudogene)
01

Overview

RNU6-1017P represents a pseudogene copy of the human U6 small nuclear RNA (snRNA) gene, found within the genome but not transcribed into a functional RNA product. Pseudogenes like RNU6-1017P are formed by the duplication or retrotransposition of functional snRNA genes; they frequently retain sequence similarity to parent genes such as U6 snRNA but typically lack regulatory features for transcription or encode nonfunctional RNA due to mutations or truncations. U6 snRNA itself is a component of the spliceosomal machinery crucial for pre-mRNA splicing, but pseudogenes like RNU6-1017P do not contribute to this process. There is no evidence that RNU6-1017P is biologically functional, therapeutically relevant, or implicated in disease. Pseudogenes are prevalent for U6 snRNA in vertebrate genomes and most are nonfunctional. Sequence analysis of similar U6 snRNA pseudogenes shows they may contain parts of the functional gene but exhibit mutations, rearrangements, or duplications (e.g., direct repeats) that render them inactive. Gene databases (e.g., Ensembl, NCBI, BioGPS) list RNU6-1017P as a pseudogene without functional annotation, protein product, or disease relevance. RNU6-1017P (RNA, U6 small nuclear 1017, pseudogene) is a nonfunctional pseudogene derived from the U6 snRNA gene. It is not a canonical drug or therapeutic target, has no known biological function or disease role, and should not be considered a molecular target for pharmacological intervention.

Other names
RNU6-1017PU6 snRNA pseudogene 1017RNA, U6 small nuclear 1017 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1017, pseudogene (RNU6-1017P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1017, pseudogene (RNU6-1017P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call